Samsung BioLogics (SBL) recently entered a new era by signing a "first of its kind" deal with a US bio-pharmaceutical...
Read more
GlaxoSmithKline plc announced a five-year collaboration with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the...
Read more
Savara Inc. , an orphan lung disease company announced top line data from IMPALA, a pivotal Phase 3 clinical study...
Read more
Hamilton Company and Enable Biosciences are pleased to announce their collaboration to provide fully automated processing of up to 96...
Read more
Celgene has announced that the US FDA has approved Revlimid (lenalidomide) in combination with rituximab (R2) for patients with previously...
Read more
ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today...
Read more
For an extended time, IBT has consulted with the US FDA on how the company’s planned Phase III study should...
Read more
Allergan plc announced the expansion of the PLEDGE program with a fifth study now evaluating relamorelin, an investigational, ghrelin agonist...
Read more
Circuit Clinical, one of the nation's largest integrated research organizations dedicated to empowering patients to choose clinical research as a...
Read more
Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering CCM therapy, announced that the first patient to receive...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
